Collation and data-mining of \literature bioactivity data for drug discovery

Biochemical Society Transactions

Volumn 39, Issue 5, 2011, Pages 1365-1370

  Bellis, Louisa J ^a   Akhtar, Ruth ^a   Al Lazikani, Bissan ^b   Atkinson, Francis ^a   Bento, A Patricia ^a   Chambers, Jon ^a   Davies, Mark ^a   Gaulton, Anna ^a   Hersey, Anne ^a   Ikeda, Kazuyoshi ^a   Krüger, Felix A ^a   Light, Yvonne ^a   McGlinchey, Shaun ^a   Santos, Rita ^a   Stauch, Benjamin ^a   Overington, John P ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bioactivity data; ChEMBL; Data mining; Drug discovery; Structure activity relationship (SAR)

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; CHEMBL 1018316; G PROTEIN COUPLED RECEPTOR; IMATINIB; PROTEIN; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIHYPERTENSIVE ACTIVITY; CELL LINE; CHEMBL DATABASE; CHEMISTRY; CODING; CONFERENCE PAPER; DATA BASE; DATA MINING; DRUG ACTIVITY; DRUG DESIGN; DRUG DEVELOPMENT; DRUG SYNTHESIS; GENE; GENE IDENTIFICATION; HUMAN; MEDICAL INFORMATION SYSTEM; MYSQL DATABASE; NONHUMAN; ONLINE SYSTEM; ORGANISM; PRIORITY JOURNAL; PUBLICATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; COMPUTATIONAL BIOLOGY; DATA MINING; DATABASES, FACTUAL; DRUG DISCOVERY; GENOMICS; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80053361809     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391365     Document Type: Conference Paper

References (36)

1. Sneader, W. (1996) Drug Prototypes and Their Exploitation, Wiley and Sons, Chichester
2. Degtyarenko, K., De Matos, P., Ennis, M., Hastings, J., Zbinden, M., McNaught, A., Alcantara, R., Darsow, M., Guedj, M. and Ashburner, M. (2007) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344-D350 (Pubitemid 351149747)
3. Irwin, J.J. and Shoichet, B.K. (2005) ZINC: a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45, 177-182 (Pubitemid 40736970)
4. Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B.A., Suzek, T.O., Wang, J., Xiao, J., Zhang, J. and Bryant, S.H. (2009) An overview of the PubChem BioAssay resource. Nucleic Acids Res. 38, D255-D266
5. Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V. et al. (2010) DrugBank 3.0: a comprehensive resource for "Omics" research on drugs. Nucleic Acids Res. 39, D1035-D1041
6. Sharman, J.L., Mpamhanga, C.P., Spedding, M., Germain, P., Staels, B., Dacquet, C., Laudet, V. and Harmar, A.J. (2010) IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data. Nucleic Acids Res. 39, D534-D538
7. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M. and Hirakawa, M. (2009) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360
8. DeLano, W.L. (2005) The case for open-source software in drug discovery. Drug Discovery Today 10, 213-217
9. Gaulton, A. and Overington, J.P. (2010) Role of open chemical data in aiding drug discovery and design. Future Med. Chem. 2, 903-907
10. Apweiler, R., Bairoch, A., Wu, C.H., Barker, W.C., Boeckmann, B., Ferro, S., Gasteiger, E., Huang, H., Lopez, R., Magrane, M. et al. (2004) UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 32, D115-D119 (Pubitemid 38081617)
11. Stein, S.E., Heller, S.R. and Tchekhovskoi, D. (2003) An open standard for chemical structure representation: the IUPAC Chemical Identifier. In Proceedings of the 2003 International Chemical Information Conference, pp. 131-143, Infornotics, Tetbury
12. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 46, 3-26 (Pubitemid 33653411)
13. Bonner, T.I., Buckley, N.J., Young, A.C. and Brann, M.R. (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237, 527-532 (Pubitemid 17125922)
14. Kubo, T., Fukuda, K., Mikami, A., Maeda, A., Takahashi, H., Mishina, M., Haga, T., Haga, K., Ichiyama, A. and Kangawa, K. (1986) Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature 323, 411-416 (Pubitemid 16026268)
15. Bonner, T.I., Young, A.C., Brann, M.R. and Buckley, N.J. (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1, 403-410
16. Overington, J.P., Al-Lazikani, B. and Hopkins, A.L. (2006) How many drug targets are there? Nat. Rev. Drug Discovery 5, 993-996 (Pubitemid 44835126)
17. Metz, J.T., Johnson, E.F., Soni, N.B., Merta, P.J., Kifle, L. and Hajduk, P.J. (2011) Navigating the kinome. Nat. Chem. Biol. 7, 200-202
18. Gamo, F., Sanz, L.M., Vidal, J., Cozar, C.D., Alvarez, E., Lavandera, J., vanderwall, D.E., Green, D.V.S., Kumar, V., Hasan, S. et al. (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305-310
19. Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrián, F., Matzen, J.T., Anderson, P. et al. (2008) In silico activity profiling reveals the mechanism of action of anti-malarials discovered in a high-throughput screen. Proc. Natl. Acad. Sci. U.S.A. 105, 9059-9064
20. Guiguemde, W.A., Shelat, A.A., Bouck, D., Duffy, S., Crowther, G.J., Davis, P.H., Smithson, D.C., Connelly, M., Clark, J., Zhu, F. et al. (2010) Chemical genetics of Plasmodium falciparum. Nature 465, 311-315
21. Manning, G., Whyte, D.B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934 (Pubitemid 35425239)
22. Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R. and Landvatter, S.W. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746
23. Hopkins, A.L., Mason, J. and Overington, J.P. (2006) Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol. 16, 127-136 (Pubitemid 43221881)
24. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Le Trong, I., Teller, D.C. and Okada, T. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745 (Pubitemid 30650186)
25. Shimamura, T., Hiraki, K., Takahashi, N., Hori, T., Ago, H., Masuda, K., Takio, K., Ishiguro, M. and Miyano, M. (2008) Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region. J. Biol. Chem. 283, 17753-17756
26. 2 adrenergic G-protein-coupled receptor. Nature 450, 383-387
27. 1-adrenergic receptor in a detergent-resistant form. Proc. Natl. Acad. Sci. U.S.A. 105, 877-882
28. 3 selective antagonist. Science 330, 1091-1095
29. Jaakola, V., Griffith, M.T., Hanson, M.A., Cherezov, V., Chien, E.Y.T., Lane, J.R., Ijzerman, A.P. and Stevens, R.C. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211-1217
30. Wu, B., Chien, E.Y.T., Mol, C.D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F.C. et al. (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071
31. Paolini, G.V., Shapland, R.H.B., van Hoorn, W.P., Mason, J.S. and Hopkins, A.L. (2006) Global mapping of pharmacological space. Nat. Biotechnol. 24, 805-815 (Pubitemid 44086621)
32. Keiser, M.J., Setola, V., Irwin, J.J., Laggner, C., Abbas, A.I., Hufeisen, S.J., Jensen, N.H., Kuijer, M.B., Matos, R.C. and Tran, T.B. (2009) Predicting new molecular targets for known drugs. Nature 462, 175-181
33. Gleeson, M.P., Hersey, A., Montanari, D. and Overington, J.P. (2011) Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat. Rev. Drug Discovery 10, 197-208
34. Leeson, P.D. and Springthorpe, B. (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discovery 6, 881-890 (Pubitemid 350042396)
35. Hopkins, A.L., Groom, C.R. and Alex, A. (2004) Ligand efficiency: a useful metric for lead selection. Drug. Discovery Today 9, 430-431 (Pubitemid 38510559)
36. Abad-Zapatero, C., Perišić, O., Wass, J., Bento, A.P., Overington, J.P., Al-Lazikani, B. and Johnson, M.E. (2010) Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation. Drug Discovery Today 15, 804-811